NovAliX will be present at the 12th Annual Tumour Models in London, UK, from December 6 to 7, 2023. Delivering scientific excellence with an integrated Drug Discovery platform from hit finding to lead optimization, NovAliX provides considerable pharmacology resources in various therapeutic areas:
- infectious diseases
- kidney diseases
- metabolic disorders
Both stand-alone and integrated drug discovery projects, from target validation to the selection of the final clinical candidate, are supported.
About the Tumour Models London
Organized by Hanson Wade, Tumour Models London gathers pioneering drug developers and technology providers in order to increase clinical translability and ensure effective treatments for patients. The forum will feature exclusive case studies in model predictability as well as assessed strategies to boost candidate therapeutic and clinical confidence.
Contact NovAliX at the forum
Needing support for your therapeutic projects? Attending also Tumour Models? Do not hesitate to contact our NovAlix expert in Drug Discovery:
Alessandro Taddei, Director Business Development Drug Discovery